Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01781104 · ClinicalTrials.gov registry record · Phase 2
Phase 2 Study to Evaluate Safety and Efficacy of RM-131 Administered to Patients With Chronic Constipation
A Phase 2 study of Constipation, sponsored by Motus Therapeutics.
- Completed
- Registry status
- Phase 2
- Development phase
- 48
- Enrollment target
- 3
- Study locations
NCT01781104 is a Phase 2 study of Constipation that has completed, run by Motus Therapeutics. The registered enrollment target is 48 participants, below the 205-participant average among 54 other Constipation trials with a reported enrollment target (77% lower). The trial reports 3 study locations across 3 states.
The verdict
NCT01781104, a Phase 2 study of Constipation, has completed, sponsored by Motus Therapeutics.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 48 participants
- Enrollment target
- 3
- Study locations
Study Summary
The purpose of this study is to evaluate safety and tolerability as well as the effects of RM-131 on colonic transit, bowel consistency, bowel habits, abdominal pain, and other abdominal symptoms in patients with chronic constipation.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG RM-131
Study Locations (3)
Arizona
- Mayo Clinic Arizona - Scottsdale
Florida
- Mayo Clinic Florida - Jacksonville
Minnesota
- Mayo Clinic Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2013-03 |
| Est. Completion | 2014-10 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01781104
The ClinicalTrials.gov registry entry for NCT01781104 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 205-participant average among 54 other Constipation trials with a reported enrollment target (77% lower). The listed sponsor is Motus Therapeutics, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Constipation appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT01781104 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Arizona, Florida, Minnesota.
Frequently Asked Questions
What is clinical trial NCT01781104 about?
NCT01781104 is a clinical study titled "Phase 2 Study to Evaluate Safety and Efficacy of RM-131 Administered to Patients With Chronic Constipation". The purpose of this study is to evaluate safety and tolerability as well as the effects of RM-131 on colonic transit, bowel consistency, bowel habits, abdominal pain, and other abdominal symptoms in patients with chronic constipation.
What is the current status of trial NCT01781104?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 48 participants. The study started on 2013-03. Estimated completion is 2014-10.
What conditions does trial NCT01781104 study?
This clinical trial studies the following conditions: Constipation.
What interventions are being tested in trial NCT01781104?
The interventions under investigation include: Placebo (DRUG), RM-131 (DRUG).
Who is sponsoring clinical trial NCT01781104?
This trial is sponsored by Motus Therapeutics, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01781104 being conducted?
This trial has 3 study locations across Arizona, Florida, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Constipation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study of Microbiome Transplantation for the Treatment of Constipation and/or Significant Bloating in Patients With Systemic Sclerosis
RECRUITING · Phase 2
-
Pyridostigmine for the Treatment of Constipation in Parkinson Disease
RECRUITING · Phase 2
-
MTT for Children With ASD Who Have Gastrointestinal Disorders
ACTIVE NOT RECRUITING · Phase 2
-
Use of a Squatting Assist Device in Patients With Constipation
ACTIVE NOT RECRUITING · Phase 2
-
Microbiota Transplant Therapy for Children With Both Autism Spectrum Disorder and Gastrointestinal Disorders
ACTIVE NOT RECRUITING · Phase 2
-
Methylnaltrexone for Opioid-induced Constipation in Cancer Patients
COMPLETED · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.